Riskpilot← Back to searchSign inGet full accessAliMed AB
ABActiveOrg 5590419908Ramlösavägen 104 BGeneral medical practice activities · NACE 8621Est. 20150 employees
Revenue 2024
SEK 68K
0% vs 2023
EBITDA margin
81.9%
-4% vs 2023
Equity ratio
103.7%
Financial strength
Net profit 2024
SEK 45K
-3% vs 2023
| Revenue | SEK 68K | +0% |
| EBITDA | SEK 55K | -4% |
| Net profit | SEK 45K | -3% |
| Total assets | SEK 181K | +17% |
| Equity | SEK 187K | +31% |
| Employees | 0 | — |
Legal name
AliMed AB
Org number
5590419908
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 december 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom medicin med uthyrning av läkare, sjuksköterskor och övrig sjukvårdspersonal. Bolaget skall även bedriva läkarpraktik med estetiska behandlingar med injektioner, laser och mindre kirurgiska ingrepp.
Address
Ramlösavägen 104 B
Email
ali.alshatrawi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 126 | 114 | 107 | 68 | 68 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 121 | 103 | 95 | 58 | 55 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 121 | 103 | 95 | 58 | 55 |
| Net financials | — | — | −0 | 1 | 1 |
| Profit before tax | 171 | 103 | 95 | 58 | 56 |
| Tax | −37 | −21 | −20 | −12 | −11 |
| Net profit | 134 | 82 | 75 | 46 | 45 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 554 | 201 | 248 | 155 | 181 |
| Equity | 464 | 146 | 221 | 143 | 187 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 90 | 55 | 26 | 12 | −7 |
| Total debt | 90 | 55 | 26 | 12 | −7 |
EBITDA margin
81.9%
This company
15.8%
Market median
+418% vs market
20202024
Equity ratio
103.7%
This company
38.2%
Market median
+171% vs market
20202024
Return on equity
23.9%
This company
18.4%
Market median
+30% vs market
20202024
Net profit margin
66.3%
This company
8.1%
Market median
+719% vs market
20202024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20202024
Debt / equity
-0.04×
This company
0.62×
Market median
+106% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AliMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marwa Issam Jihad | Deputy Board Member | 0 companies |
| Ali Adil Al-Shatrawi | Board of Directors | 0 companies |